95301 ⎘
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
Somatostatin receptor subtype 4 (SSTR4) agonists
#2402MDM2-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
#2403Cysteine protease inhibitors and uses thereof
#2404Heterocyclic amides as kinase inhibitors
#2405Alkynyl pyridine-substituted amide compound and pesticide
#2406(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
#2407Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists
#2408Cyclopropanamine compound and use thereof
#2409Compounds, compositions, and methods for increasing CFTR activity
#2410Compounds, compositions, and methods for increasing CFTR activity
#2411Cycloalkane derivatives
#24124-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase
#2413Anti-alphavbeta1 integrin compounds and methods
#2414Therapeutic compounds
#2415NOVEL PYRIDINE DERIVATIVES
#2416Compositions and methods for treating cancer
#2417Syk inhibitors
#2418PRMT5 inhibitors and uses thereof
#2419Bicyclic heterocyclic derivatives as bromodomain inhibitors
#2420Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
#2421Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
#2422Isoxazoline derivatives as insecticides
#2423Therapeutic compounds
#24241,4-substituted piperidine derivatives
#2425Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
#2426Antimicrobial agents
#2427Azoline compounds
#2428Cyclic peroxides as prodrugs for selective delivery of agents
#2429Fused heterocyclic compounds as ion channel modulators
#2430Amide compounds for treatment of complement mediated disorders
#2431Quinazolines as potassium ion channel inhibitors
#2432ENDOPARASITE CONTROL AGENT
#2433COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#2434Compositions and methods for inhibiting cytochrome P450
#2435TRPV1 antagonists including dihydroxy substituent and uses thereof
#2436Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
#2437Deuterium-enriched pioglitazone
#2438Compounds for use as GPR120 agonists
#2439Heterocycle amines and uses thereof
#2440Bicyclic-fused heteroaryl or aryl compounds
#2441Benzamide and nicotinamide compounds and methods of using same
#2442Cytotoxic tubulysin compounds for conjugation
#2443Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
#2444Separation method for active pharmaceutical ingredients (apis) from excipients in pharmaceutical formulations
#2445Substituted benzooxadiazole DNA-PK inhibitors
#2446Tizoxanide carbamate and pharmaceutical use thereof
#2447Factor XIa inhibitors
#2448Tubulysin derivatives
#2449Triazolone compounds as mPGES-1 inhibitors
#24502-acylaminopropoanol-type glucosylceramide synthase inhibitors
#2451Substituted bicyclic heteroaryl compounds as RXR agonists
#2452Pyrimidinyloxy benzene derivatives as herbicides
#2453ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS
#2454Histone demethylase inhibitors
#2455Indole compound
#2456Bromodomain inhibitors
#2457Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
#2458Sweet flavor modifier
#2459Tricyclic sulfones as RORγ modulators
#2460Modulators of and methods of making and using thereof
#2461Substituted 6,5-fused bicyclic heteroaryl compounds
#2462Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity
#2463MONOBACTAMS AND METHODS OF THEIR SYNTHESIS AND USE
#2464Thiazole-substituted aminoheteroaryls as Spleen Tyrosine Kinase inhibitors
#2465C-6 spirocarbocyclic iminothiadiazine dioxides as BACE inhibitors, compositions, and their use
#2466BICARBOCYCLIC AND TRICARBOCYCLIC ETHYNYL DERIVATIVES AND USES OF SAME
#2467Thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase
#2468Sulfone amide linked benzothiazole inhibitors of endothelial lipase
#2469Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
#2470Thiazole compound and its use in pest control
#2471TRPV1 antagonists including dihydroxy substituent and uses thereof
#2472Oxime-substituted amide compound and pest control agent
#2473Small molecule modifiers of the Hec1-Nek2 interaction in G2/M
#2474Compound, organic cation transporter 3 detection agent, and organic cation transporter 3 activity inhibitor
#2475Inhibitor compounds of phosphodiesterase type 10A
#2476RORγ modulators
#2477Heterocyclic compounds for the treatment of neurological and psychological disorders
#24784-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors
#2479Benzamides and nicotinamides as Syk modulators
#2480Compounds useful as modulators of TRPM8
#2481Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicaments
#2482Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
#2483Cyclopropanamine compound and use thereof
#2484Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
#2485ADENOSINE A1 AGONISTS AS MEDICAMENTS FOR KIDNEY DISORDERS
#2486Cyclopropanamine compound and use thereof
#2487Biaryl inhibitors of Bruton's tyrosine kinase
#2488Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease
#2489HIV protease inhibitors
#2490N-arylmethyl sulfonamide negative modulators of NR2A
#2491Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
#2492GLP-1 receptor stabilizers and modulators
#2493Compositions and methods for treating respiratory injury or disease
#2494Methods of enhancing cell survival of stem cells
#2495Compounds, compositions and methods for inhibiting CNKSR1
#24962-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease
#2497Methods of promoting wound healing using CRM1 inhibitors
#2498NOVEL COMPOUNDS AS JNK KINASE INHIBITORS
#2499ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
#2500Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors
#2501INSECTICIDAL COMPOUNDS
#2502Viral replication inhibitors
#2503Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
#2504Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
#2505Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
#2506Preparation of cobicistat intermediates
#2507Quinazoline derivatives as TAM family kinase inhibitors
#2508S1P3 antagonists
#2509Pyrrolidinones as herbicides
#2510Antifungal treatment
#2511Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor 1
#2512CERTAIN HETEROCYCLES, COMPOSITIONS THEREOF, AND METHODS FOR THEIR USE
#2513Substituted pyridine derivatives useful as GSK-3 inhibitors
#2514Pyrazole derivatives as TNIK, IKKϵ and TBK1 inhibitor and pharmaceutical composition comprising same
#2515IDO inhibitors
#2516Disperse dyes, their preparation and their use
#2517Heteroaryloxycarbocyclyl Compounds as PDE 10 Inhibitors
#2518Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
#2519Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
#2520Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound
#25216-aminoisoquinoline compounds
#2522Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
#2523SPIROCYCLIC DIHYDRO-THIAZINE AND DIHYDRO-OXAZINE BACE INHIBITORS, AND COMPOSITIONS AND USES THEREOF
#2524Pro-drugs of NSAIAs with very high skin and membranes penetration rates and their new medicinal uses
#2525Compounds and methods for the enhanced degradation of targeted proteins
#25263-indol substituted derivatives, pharmaceutical compositions and methods for use
#2527Antibacterial thiazolecarboxylic acids
#2528Tetrahydro-benzodiazepinones
#2529DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE
#2530Tetrazolinone compound and use thereof
#2531Substituted benzamides
#2532Substituted sulfonamide compounds
#2533Anti-alphavbeta1 integrin inhibitors and methods of use
#2534CRYSTALLINE DASATINIB PROCESS
#2535Quinazoline derivative
#2536C6-spiro iminothiadiazine dioxides as BACE inhibitors, compositions, and their use
#2537CYCLIC PROTEIN TYROSINE KINASE INHIBITORS
#2538BENZOFURAZAN ANTI-AMYLOID COMPOUNDS AND METHODS
#2539Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#2540Compounds
#2541Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
#25422-acylaminothiazoles for the treatment of cancer
#2543Synthesis of novel inhibitors of isoprenoid biosynthesis (ISPF)
#2544Benzazepine dicarboxamide compounds
#2545Alkylene derivatives
#2546Tetrazolinone compound and use thereof
#2547SUBSTITUTED BENZENE COMPOUNDS
#2548Heteroaryl Syk inhibitors
#2549Substituted uracils as chymase inhibitors
#2550Quinazoline derivatives, compositions, and uses related thereto
#25514-methylsulfonyl-substituted piperidine urea compounds
#2552Process for the industrial synthesis of lurasidone
#2553Deoxycytidine kinase inhibitors
#25541-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof
#2555PHENOXY THIOPHENE SULFONAMIDES AND OTHER COMPOUNDS FOR USE AS INHIBITORS OF BACTERIAL GLUCURONIDASE
#2556AZACYCLIC COMPOUNDS
#25572,4-thiazolidinedione derivatives in the treatment of central nervous system disorders
#2558Indanyloxydihydrobenzofuranylacetic acids
#2559Tetrazolinone compound and use thereof
#2560Benzazepine ketone compounds as glycogen phosphorylase inhibitor, preparation method therefor, and medical uses
#2561Glucosylceramide synthase inhibitors for the treatment of diseases
#2562Cyanotriazole compounds
#2563Heterocyclic compound
#2564Metformin salts to treat Type2 diabetes
#2565GLP-1 receptor modulators
#25661,2- bis-sulfonamide derivatives as chemokine receptor modulators
#2567C5-spiro iminothiazine dioxides as BACE inhibitors, compositions, and their use
#2568Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders
#2569COMT inhibiting methods and compositions
#2570Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists
#2571TRPV1 antagonists including dihydroxy substituent and uses thereof
#2572COMT inhibiting methods and compositions
#2573Heterocyclic amide compound and herbicide
#2574SODIUM CHANNEL MODULATORS FOR THE TREATMENT OF PAIN AND DIABETES
#2575SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS
#2576Substituted quinoxalines as FGFR kinase inhibitors
#2577FUNGICIDAL COMPOSITIONS
#2578GLP-1 receptor modulators
#2579PRMT5 inhibitors and uses thereof
#2580Compounds and methods for the targeted degradation of androgen receptor
#2581Biaryl acyl-sulfonamide compounds as sodium channel inhibitors
#2582Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
#2583HETEROCYCLIC COMPOUNDS AND USES THEREOF
#2584Prodrugs of amino quinazoline kinase inhibitor
#2585Heteroaryl amides as inhibitors of protein aggregation
#2586Substituted pyrimidine compounds, compositions and medicinal applications thereof
#2587Tetrazolinone compound and use of same
#2588N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide for control of agricultural/horticultural pests
#2589Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
#2590COBICISTAT DICHLOHYDRATE SALT
#25913-substituted cyclopentylamine derivatives
#2592Methods and compositions for selective and targeted cancer therapy
#2593Benzimidazolyl-methyl urea derivatives as ALX receptor agonists
#2594IDO inhibitors
#2595Pi-kinase inhibitors with anti-infective activity
#2596Indole amide compound as inhibitor of necrosis
#2597COMPOUNDS FOR TREATMENT OF DRUG RESISTANT AND PERSISTENT TUBERCULOSIS
#2598Multi-targeted Ubenimex prodrug derivative and preparation method and use thereof
#2599Therapeutic agent for ophthalmic disease
#2600Anthelmintic compounds and compositions and method of using thereof
#2601Aminopyrimidine derivatives for use as modulators of kinase activity
#2602Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
#2603Processes for preparing tubulysins
#2604Hydroxy containing FXR (NR1H4) modulating compounds
#2605Inhibitors of LC3/ATG3 interaction and their use in the treatment of cancer
#26063,5-diaminopyrazole kinase inhibitors
#260711-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonists
#2608Synthesis of new benzothiazole derivatives as potential anti-tubercular agents
#2609Myc modulators and uses thereof
#2610Compounds and methods for kinase modulation, and indications therefor
#2611COMPOSITIONS AND METHODS FOR MODULATING THE ACTIVITY OF EPSTEIN-BARR NUCLEAR ANTIGEN 1
#2612Salts of Dasatinib in crystalline form
#2613Salts of dasatinib in amorphous form
#2614Aryl sultam derivatives as RORc modulators
#2615AUTOTAXIN INHIBITORS
#2616Indole derivatives and their use in neurodegenerative diseases
#2617N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof
#2618N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer
#26192,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer
#2620SUSTAINED-RELEASE FORMULATION FOR INJECTION
#2621Pesticide compounds
#2622Aryl lactam kinase inhibitors
#2623Benzimidazole derivatives as selective proteine kinase inhibitors
#2624Pyridyl inhibitors of hedgehog signalling
#2625USE OF SELECTED PYRIDONE CARBOXAMIDES OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS
#2626Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereof
#2627Bicyclyl-Substituted Isothiazoline Compounds
#2628Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
#2629IDO inhibitors
#2630Targeted nitroxide agents
#2631Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
#2632Bicyclic sulfonamide compounds as sodium channel inhibitors
#2633NOVEL PYRIDINE DERIVATIVES
#2634Methods and compositions for the treatment of cancer and related hyperproliferative disorders
#2635PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
#26362-amino 6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors
#2637α-oxoacyl amino-caprolactam
#2638N-substituted azetidine derivatives
#2639Sodium channel modulators for the treatment of pain and diabetes
#2640Substituted quinazolines as receptor-type kinase inhibitors
#26411,2,4-thiazolidin-3-one derivatives and their use in the treatment of cancer
#2642Organic dyes comprising a hydrazone moiety and their use in dye-sensitized solar cells
#2643Benzothiazole derivatives and a use thereof for the treatment of cancer
#26442,3-butanediamide epoxide compound and preparation method and use thereof
#2645Compounds, compositions and methods
#2646α-Substituted glycinamide derivative
#2647SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING BETA SECRETASE INHIBITORY ACTIVITY
#26481,2,5-substituted benzimidazoles as flap modulators
#2649POLYCYCLIC HERG ACTIVATORS
#2650Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof
#2651Pyruvate kinase activators for use in therapy
#2652Compounds and methods for the treatment of isocitrate dehydrogenase related diseases
#2653NOVEL FORMULATION OF MELOXICAM
#2654(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
#2655Compositions and methods for inhibition of the JAK pathway
#2656Hydroxyindole carboxylic acid based inhibitors for oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)
#2657Piperazine thiazole derivatives useful in the treatment of tauopathies such as Alzheimer's disease
#2658Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
#2659Inhibitors of lysine gingipain
#2660Heterocyclic compounds useful for kinase inhibition
#2661Benzoisothiazole compounds and methods of treating schizophrenia
#2662Histone deacetylase inhibitors
#2663Modulators of cystic fibrosis transmembrane conductance regulator
#2664Substituted phenylazole derivative
#2665PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS
#2666Substituted heteroaryl compounds and methods of use thereof
#2667Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same
#2668Sulfur derivatives as chemokine receptor modulators
#2669Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
#2670Tetrahydroisoquinoline derivatives, pharmaceutical compositions and uses thereof
#2671Compositions useful in treating brain-related diseases or disorders and methods using same
#2672Inhibitors of leukotriene A4 hydrolase
#2673Compounds as diacylglycerol acyltransferase inhibitors
#2674Therapeutic compounds
#2675Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
#2676Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
#2677Thiazole-based inhibitors of scavenger receptor BI
#2678Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
#2679N-myristoyl transferase inhibitors
#2680AMINO-QUINOLINES AS KINASE INHIBITORS
#2681Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
#2682COMPOUNDS FOR USE IN SCREENING METHODS FOR SPINAL MUSCULAR ATROPHY
#2683NOVEL PYRIMIDINE AND PYRIDINE COMPOUNDS AND USAGE THEREOF
#2684Small molecule mediated transcriptional induction of E-cadherin
#2685Compounds useful as antibiotic tolerance inhibitors
#2686Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
#2687Fungicidal amides
#2688TREATMENT OF MALARIA USING INHIBITORS OF THE ISPD ENZYME IN THE NON-MEVALONATE PATHWAY
#2689Bicyclic sulfonamide compounds as sodium channel inhibitors
#2690BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE
#2691Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
#2692Sodium channel modulators for the treatment of pain
#2693NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY
#2694Heterocyclic derivative and pharmaceutical drug
#26951,2,5-Substituted benzimidazoles as flap modulators
#2696THERAPEUTIC COMPOUNDS AND COMPOSITIONS
#2697Serotonin receptor modulators
#2698Aminoquinazoline derivatives and their salts and methods of use thereof
#2699Method of preparing glucosylceramide synthase inhibitors
#2700Dihydroxy aromatic heterocyclic compound